ALAB250117C80000
- 64.76
- +1.86+2.96%
Astera Labs Newsroom
Morgan Stanley Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $142
Morgan Stanley Reaffirms Their Buy Rating on Astera Labs, Inc. (ALAB)
Astera Labs Analyst Ratings
Morgan Stanley Maintains Overweight on Astera Labs, Raises Price Target to $142
Morgan Stanley Boosts Price Target on Astera Labs to $142 From $94, Keeps Overweight Rating
Barclays Sticks to Its Buy Rating for Astera Labs, Inc. (ALAB)
Roth MKM Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $130
Analysts' Top NA Picks: Ibotta, Inc. Class A (IBTA), Astera Labs, Inc. (ALAB)
Analysts Offer Insights on NA Companies: GE Vernova Inc. (GEV) and Astera Labs, Inc. (ALAB)
Astera Labs Analyst Ratings
Citigroup Initiates Coverage On Astera Labs With Buy Rating, Announces Price Target of $120
Stifel Maintains Astera Labs(ALAB.US) With Buy Rating, Maintains Target Price $100
J.P. Morgan Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $110
A Quick Look at Today's Ratings for Astera Labs(ALAB.US), With a Forecast Between $100 to $110
Astera Labs Is Maintained at Overweight by Barclays
Astera Labs Analyst Ratings
A Quick Look at Today's Ratings for Astera Labs(ALAB.US), With a Forecast Between $80 to $100
Deutsche Bank Raises Astera Labs Price Target to $100 From $60, Maintains Buy Rating
Astera Labs, Inc: Strong Quarterly Performance and Promising Growth Trajectory Drive Buy Rating
Barclays Keeps Their Buy Rating on Astera Labs, Inc. (ALAB)